FDA Launches Medical Device Identification Site

Federal regulators launched a new website this week, which is designed to provide the public access to key information about medical devices and help identify products that may contain dangerous defects that pose a risk for consumers.

The FDA’s Global Unique Device Identification Database (GUDID) is a database of key device identification information that is updated daily, which will be run in collaboration with the National Library of Medicine. The information provided by the site is available to the patients, caregivers, industry and the medical community.

The AccessGUDID website was launched on May 4, allowing consumers to search either for information about a specific medical device, or they can download all of the data from the system at once.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The Unique Device Identifiers (UDI) will include a Device Identifier that is a unique numeric or alphanumeric code that is specific to the device version or model, as well as Production Identifiers (PI), which are numeric or alphanumeric codes that identify specific product information, including:

  • Lot or batch number
  • Serial number
  • Expiration date
  • Manufacturing date

In addition, there is a distinct identification code for Human Cell, Tissue or Cellular or Tissue-Based Products (HCT/P) that allows the manufacturer to identify the specific donor. However, the PI is not stored in GUDID, only the Device Identifier. The FDA says the GUDID does not collect or contain patient information.

“UDIs will be phased in over several years, starting with the highest risk devices, such as heart valves and pacemakers,” the FDA notes. “Because of this, records for only a fraction of devices currently in use have been submitted to GUDID.”

In July 2014, the FDA finalized guidance on the creation of a Global Unique Device Identification Database (GUDID), following the issuance of a final rule on the unique device identifier (UDI) program issued in September 2013.

The FDA intends to phase in the UDI system, starting with high-risk devices. However, some low-risk medical devices will be partially or fully exempt. The agency first proposed the rule in July 2012.

In the past, the U.S. public often had to wait for problems to be noticed, since adverse event reports were not consistently tracked and the manufacturer was largely responsible for identifying issues after medical devices were introduced. The first warnings about problems with medical devices frequently came from oversees, since Australia and the U.K. have extensive databases for medical devices hip replacement systems and knee implants.

1 Comments

  • DallasMay 9, 2015 at 4:40 am

    We blame the manufactures but what about the insurance companies that are paying for it they're paying these out rages prices and they're not paying any attention to what we're getting for money we pay them we have a problem with her doctor or our product Who do we go after the manufacture and the doctor why don't we go after the insurance company I feel they should be responsible they paid for d[Show More]We blame the manufactures but what about the insurance companies that are paying for it they're paying these out rages prices and they're not paying any attention to what we're getting for money we pay them we have a problem with her doctor or our product Who do we go after the manufacture and the doctor why don't we go after the insurance company I feel they should be responsible they paid for don't they know what they're buying or did they just pay and buy whatever they think Americans need

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL
Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL (Posted yesterday)

In advance of a a conference this week, lawyers report that progress is being made to prepare a group of federal Gardasil vaccine lawsuits for early test trials, to help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation.

Enfamil Lawsuit Claims Preemie Developed NEC After Being Fed Cow's Milk-Based Infant Formula
Enfamil Lawsuit Claims Preemie Developed NEC After Being Fed Cow's Milk-Based Infant Formula (Posted 2 days ago)

Cow's milk-based infant formula products are dangerous for premature infants, according to a mother's recent Enfamil lawsuit, filed after her newborn developed necrotizing enterocolitis and suffered through surgery and continuing negative health effects.

Ozempic MDL Lawsuits Reassigned To New Judge For Further Pretrial Proceedings
Ozempic MDL Lawsuits Reassigned To New Judge For Further Pretrial Proceedings (Posted 5 days ago)

All lawsuits over Ozempic, Mounjaro, Wegovy and other GLP-1 RA drugs to U.S. District Judge Karen S. Marston, following the death last month of the judge originally appointed to preside over all claims involving stomach paralysis and other gastrointestinal injuries.